We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+4.92%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
AUM
$8.47B
AUM Growth
-$26.4M
Cap. Flow
-$317M
Cap. Flow %
-3.74%
Top 10 Hldgs %
16.75%
Holding
2,295
New
113
Increased
604
Reduced
562
Closed
131

Top Sells

Rank Stock Value
1
DD icon
DuPont de Nemours
DD
+$44.9M
2
BKNG icon
Booking.com
BKNG
+$30.5M
3
TWX
Time Warner Inc
TWX
+$22.2M
4
MON
Monsanto Co
MON
+$15.5M
5
AAPL icon
Apple
AAPL
+$14.5M

Sector Composition

Rank Sector Weight
1 Technology 17.18%
2 Financials 16.58%
3 Healthcare 12.69%
4 Industrials 10.83%
5 Consumer Discretionary 9.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FOSL icon
1351
Fossil Group
FOSL
$311M
$555K 0.01%
20,656
SPSC icon
1352
SPS Commerce
SPSC
$2.75B
$555K 0.01%
15,100
MLCO icon
1353
Melco Resorts & Entertainment
MLCO
$2.14B
$554K 0.01%
19,800
GHDX
1354
DELISTED
Genomic Health, Inc.
GHDX
$554K 0.01%
10,989
+2,179
+25% +$86.5K
UVE icon
1355
Universal Insurance Holdings
UVE
$1.18B
$553K 0.01%
15,753
CVNA icon
1356
Carvana
CVNA
$79.7B
$552K 0.01%
66,350
+31,445
+90% +$189K
RWT
1357
Redwood Trust
RWT
$592M
$552K 0.01%
33,524
HFWA icon
1358
Heritage Financial
HFWA
$1.22B
$550K 0.01%
15,777
+3,133
+25% +$100K
LKFN icon
1359
Lakeland Financial Corp
LKFN
$1.55B
$549K 0.01%
11,384
+1,361
+14% +$66.2K
NTRI
1360
DELISTED
NutriSystem, Inc.
NTRI
$549K 0.01%
14,262
AIMT
1361
DELISTED
Aimmune Therapeutics
AIMT
$547K 0.01%
20,346
+3,261
+19% +$99.8K
STBZ
1362
DELISTED
State Bank Financial Corporation. Common Stock
STBZ
$547K 0.01%
16,379
GES
1363
DELISTED
Guess Inc
GES
$546K 0.01%
25,521
-4,964
-16% -$114K
CBPX
1364
DELISTED
CONTINENTAL BUILDING PRODUCTS, INC.
CBPX
$546K 0.01%
17,313
BJRI icon
1365
BJ's Restaurants
BJRI
$1.48B
$545K 0.01%
+9,083
New +$487K
CHCO icon
1366
City Holding Co
CHCO
$2.07B
$545K 0.01%
7,242
AZZ icon
1367
AZZ Inc
AZZ
$4.55B
$544K 0.01%
12,522
MGPI icon
1368
MGP Ingredients
MGPI
$381M
$543K 0.01%
6,119
+679
+12% +$60.9K
PIPR icon
1369
Piper Sandler
PIPR
$5.34B
$543K 0.01%
28,252
CYS
1370
DELISTED
CYS Investments Inc.
CYS
$543K 0.01%
72,423
+13,426
+23% +$96K
EEM icon
1371
iShares MSCI Emerging Markets ETF
EEM
$30.4B
$538K 0.01%
12,405
+1,300
+12% +$60.2K
AMSF icon
1372
AMERISAFE
AMSF
$517M
$537K 0.01%
9,298
SYKE
1373
DELISTED
SYKES Enterprises Inc
SYKE
$536K 0.01%
18,634
IBP icon
1374
Installed Building Products
IBP
$6.46B
$535K 0.01%
9,469
MNR
1375
DELISTED
Monmouth Real Estate Investment Corp
MNR
$535K 0.01%
32,365

Similar funds

MetLife Investment Management's Q2 2018 Portfolio in Review

As of Q2 2018, MetLife Investment Management held 2,295 positions worth $8.47B, down 0.31% from $8.49B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

MetLife Investment Management withdrew a net $317M in Q2 2018, closing 131 positions and reducing 562 holdings. Its most notable exit was DuPont de Nemours, an estimated $44.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

Against the trend, MetLife Investment Management opened a new position in Bank of New York Mellon worth $16M.

  • MetLife Investment Management's largest Q2 2018 buy was Bank of New York Mellon: 297,519 shares worth $16M.
  • MetLife Investment Management added most to State Street SPDR S&P 500 ETF Trust in Q2 2018, an estimated $33.8M increase.
  • MetLife Investment Management's biggest Q2 2018 reduction was Apple, cutting an estimated $14.5M.
  • MetLife Investment Management fully exited DuPont de Nemours in Q2 2018, selling an estimated $44.9M.
  • MetLife Investment Management's ten largest holdings make up 17% of its $8.47B portfolio in Q2 2018.
  • MetLife Investment Management opened 113 new positions and closed 131 in Q2 2018.
  • MetLife Investment Management's portfolio value fell 0.31% quarter-over-quarter to $8.47B.

Based on MetLife Investment Management's 13F filing for Q2 2018, filed 15 Aug 2018.